Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

11125	Companies
245041	Keywords
173148	Articles
132173	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 02/20/2025 at 19:25, 1 year 7 months ago

Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
Onco-Innovations' Inka Health Corp. enters Expression of Interest with Quantify Research for collaboration in advanced data analytics and oncology research to enhance cancer treatment insights

Oncology Research Onco-Innovations Inka Health Corp. Quantify Research Advanced Data Analytics
BRIEF

published on 02/15/2025 at 00:05, 1 year 7 months ago

Onco-Innovations' Nanoparticle Technology Shows Promise in Colorectal Cancer Treatment

Colorectal Cancer Radiation Therapy Nanoparticle Technology Onco-Innovations PNKP Inhibitors
BRIEF

published on 02/15/2025 at 00:05, 1 year 7 months ago

La technologie des nanoparticules d'Onco-Innovations s'avère prometteuse dans le traitement du cancer colorectal

Cancer Colorectal Technologie Des Nanoparticules Radiothérapie Innovations Oncologiques Inhibiteurs De La PNKP
PRESS RELEASE

published on 02/15/2025 at 00:00, 1 year 7 months ago

Onco-Innovations' Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth
Onco-Innovations Limited announces promising results in slowing colorectal cancer growth using nanoparticle PNKP Compound as standalone and combination treatment, targeting cancer cells precisely

Colorectal Cancer Onco-Innovations Limited Nanoparticle Formulation PNKP Compound Targeted Therapy
BRIEF

published on 02/11/2025 at 01:05, 1 year 7 months ago

Onco-Innovations Reveals Promising Results for Cancer Treatment Technology

Cancer Treatment Colorectal Cancer Radiation Therapy Onco-Innovations PNKP Inhibitors
BRIEF

published on 02/11/2025 at 01:05, 1 year 7 months ago

Onco-Innovations révèle des résultats prometteurs en matière de technologie de traitement du cancer

Cancer Colorectal Traitement Du Cancer Radiothérapie Innovations Oncologiques Inhibiteurs De La PNKP
PRESS RELEASE

published on 02/11/2025 at 01:00, 1 year 7 months ago

Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study
Onco-Innovations Limited introduces exclusive PNKP inhibitors to enhance sensitivity of cancer cells to radiation, potentially revolutionizing targeted cancer treatments

Colorectal Cancer Radiation Therapy PNKP Inhibitors Onco-Innovations Limited Cancer Cells
BRIEF

published on 02/07/2025 at 01:35, 1 year 7 months ago

Onco-Innovations Explores AI-Driven Collaboration with Quantify Research

Cancer Treatment AI-driven Analytics Real-world Data Onco-Innovations Quantify Research
BRIEF

published on 02/07/2025 at 01:35, 1 year 7 months ago

Onco-Innovations explore la collaboration basée sur l'IA avec Quantify Research

Données Du Monde Réel Traitement Du Cancer Analyses Basées Sur L'IA Innovations Oncologiques Quantifier La Recherche
PRESS RELEASE

published on 02/07/2025 at 01:30, 1 year 7 months ago

Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
Onco-Innovations announces Expression of Interest with Quantify Research, a global healthcare data analytics leader, to explore collaborations in advanced data analytics and oncology research

Oncology Research Healthcare Data Analytics Onco-Innovations Quantify Research EOI

Accesswire

Published on 10/05/2026 at 14:45, 4 hours 25 minutes ago

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 4 hours 40 minutes ago

Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 4 hours 40 minutes ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 5 hours 10 minutes ago

Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 14:00, 5 hours 10 minutes ago

GameSquare to Present at Upcoming Investor Conferences

View all ACCESSWIRE

EQS Group

Published on 10/05/2026 at 19:00, 10 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 28 septembre 2026 au 02 octobre 2026
Published on 10/05/2026 at 18:45, 25 minutes ago

Director/PDMR Shareholding
Published on 10/05/2026 at 18:30, 40 minutes ago

init is entering the market for the management of autonomous fleets through a stake in successful Norwegian start-up
Published on 10/05/2026 at 18:00, 1 hour 10 minutes ago

2CRSi SA: Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
Published on 10/05/2026 at 18:00, 1 hour 10 minutes ago

2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of September 30, 2026

Les Echos

Published on 10/05/2026 at 18:13, 57 minutes ago

Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 57 minutes ago

Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 1 hour 10 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
Published on 10/05/2026 at 17:45, 1 hour 25 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 10/05/2026 at 17:45, 1 hour 25 minutes ago

Declaration of voting rights at the end of September 2026

View all LES ECHOS COMFI WIRE